Buffet, Bezos, and Dimon Named This Guy CEO of their Health Care Venture

The new CEO of Berkshire, Amazon, and JPMorgan’s health care venture was revealed this week.

His name is Dr. Atul Gawande and he currently practices general and endocrine surgery at Brigham and Women’s Hospital. He is also a professor at the Harvard T.H. Chan School of Public Health and Harvard Medical School.

The companies announced the news this week and has said that the new company will operate as an independent entity and will be free from profit-making incentives and constraints.

Dr. Gawande is also the founding executive director of the health systems innovation center, Ariadne Labs as well as a staff writer for The New Yorker magazine. He has four New York Times bestsellers under his belt called: “Complications,” “Better,” “The Checklist Manifesto,” and “Being Mortal.”

Warren Buffett remarked, “Talent and dedication were manifest among the many professionals we interviewed.”

“All felt that better care can be delivered and that rising costs can be checked. Jamie, Jeff and I are confident that we have found in Atul the leader who will get this important job done.”

“We need an extraordinary CEO because it takes a lot of imagination, and it takes a whole lot of execution,” Buffett previously told Yahoo Finance. “And it takes somebody that has a fervor for doing this beyond just having a job.”

Dr. Gawande commented, “I’m thrilled to be named CEO of this health care initiative. I have devoted my public health career to building scalable solutions for better health care delivery that are saving lives, reducing suffering, and eliminating wasteful spending both in the U.S. and across the world. Now I have the backing of these remarkable organizations to pursue this mission with even greater impact for more than a million people, and in doing so incubate better models of care for all. This work will take time but must be done. The system is broken, and better is possible.”

He will begin his new role as leader on July 9th.